Clinical Dossier Protected PCI with Impella®

The 2020 Clinical Dossier: Protected PCI with Impella® is a collection of data and clinical evidence supporting the use of Impe...

Protected PCI Scientific Overview

IMP-1015-16 v7...

Largest FDA Study of High-Risk PCI Patients Shows Improved Outcomes with Impella® Heart Pumps

Jeffrey J. Popma, MD, presents the latest data from the PROTECT series clinical study...

PROTECT III Data Demonstrates Impella® Reduces MACCE Compared to IABP

NPS-420...

STEMI DTU Safety and Feasibility Trial Fact Sheet

IMP-473...

Hub-Spoke Patient Transfer Packet

Use this patient transfer checklist and documentation when transferring a patient supported with an Impella® device  from the "...

Dr. O’Neill’s IQ Data and AMICS Presentation from TCT 2018

Adoption of best practices improves survival for patients with Acute Myocardial Infarction and Cardiogenic Shock (AMICS) suppor...

Renal Effects of Impella Support During Protected PCI

Dr. Michael P. Flaherty's TCT 2018 presentation on Renal Effects of Impella support during Protected PCI....

Sentara Heart Hospital PCI Algorithm

IMP-287-17 v3...

Abiomed’s Cardiogenic Shock Guidelines

The use of standardized protocols has been associated with improvement in outcomes for people in...

Impella® Program Protocol and Tools

The Impella® Program Protocol and Tools Provides Resources on Impella Best Practices Including:Data-driven protoc...

Cardiogenic Shock Clinical Dossier

Impella 2.5®, Impella CP®, Impella 5.0®, and Impella LD® heart pumps are now  FDA i...